PT666929E - Metodo para inibir a replicacao de celulas hyperproliferativas - Google Patents

Metodo para inibir a replicacao de celulas hyperproliferativas

Info

Publication number
PT666929E
PT666929E PT93924312T PT93924312T PT666929E PT 666929 E PT666929 E PT 666929E PT 93924312 T PT93924312 T PT 93924312T PT 93924312 T PT93924312 T PT 93924312T PT 666929 E PT666929 E PT 666929E
Authority
PT
Portugal
Prior art keywords
hyperproliferative cells
hyperproliferative
polypeptide
relates
adenovirus
Prior art date
Application number
PT93924312T
Other languages
English (en)
Inventor
Steven M Frisch
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Publication of PT666929E publication Critical patent/PT666929E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT93924312T 1992-10-13 1993-10-13 Metodo para inibir a replicacao de celulas hyperproliferativas PT666929E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/960,112 US5516631A (en) 1992-10-13 1992-10-13 Method of inhibiting replication of hyperproliferative cells

Publications (1)

Publication Number Publication Date
PT666929E true PT666929E (pt) 2003-08-29

Family

ID=25502805

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93924312T PT666929E (pt) 1992-10-13 1993-10-13 Metodo para inibir a replicacao de celulas hyperproliferativas

Country Status (10)

Country Link
US (2) US5516631A (pt)
EP (1) EP0666929B1 (pt)
JP (1) JP3492364B2 (pt)
AT (1) ATE240404T1 (pt)
CA (1) CA2147127A1 (pt)
DE (1) DE69332978T2 (pt)
DK (1) DK0666929T3 (pt)
ES (1) ES2194849T3 (pt)
PT (1) PT666929E (pt)
WO (1) WO1994009160A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5776743A (en) 1994-09-06 1998-07-07 La Jolla Cancer Research Foundation Method of sensitizing tumor cells with adenovirus E1A
US6326356B1 (en) 1996-10-18 2001-12-04 Board Of Regents, The University Of Texas System Suppression of neu overexpression using a mini-E1A gene
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
US5763415A (en) 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
WO1997005898A1 (en) * 1995-08-03 1997-02-20 The Johns Hopkins University School Of Medicine Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
BR0012676A (pt) 1999-07-22 2003-07-01 Newbiotics Inc Métodos para tratamento de tumores resistentes a terapia
US20040266834A1 (en) * 1999-10-14 2004-12-30 Copland John A. Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
US20040191761A1 (en) * 2003-03-27 2004-09-30 Routes John M. Modified adenoviral E1A constructs and methods of use thereof
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
WO2012071492A1 (en) 2010-11-23 2012-05-31 Georgia Tech Research Corporation Mir-200 family induces mesenchymal-to-epithelial transition (met) in ovarian cancer cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
ES2093248T3 (es) * 1990-12-04 1996-12-16 Univ Texas Metodos y composiciones para la supresion de la transformacion mediada por el neu.
US5641484A (en) * 1990-12-04 1997-06-24 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
DK0931830T3 (da) * 1993-02-16 2001-06-11 Onyx Pharma Inc Cytopatiske vira til terapi og profylakse af neoplasi

Also Published As

Publication number Publication date
ATE240404T1 (de) 2003-05-15
WO1994009160A1 (en) 1994-04-28
EP0666929A1 (en) 1995-08-16
DK0666929T3 (da) 2003-09-15
ES2194849T3 (es) 2003-12-01
DE69332978T2 (de) 2004-02-26
CA2147127A1 (en) 1994-04-28
EP0666929B1 (en) 2003-05-14
US5516631A (en) 1996-05-14
EP0666929A4 (en) 1996-07-10
US5866550A (en) 1999-02-02
JPH08504573A (ja) 1996-05-21
JP3492364B2 (ja) 2004-02-03
DE69332978D1 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
PT666929E (pt) Metodo para inibir a replicacao de celulas hyperproliferativas
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
AU560340B2 (en) Rennin from recombinant dna
ES8800987A1 (es) Metodo de produccion del factor viii:c humano
PL272245A1 (en) Plant cells transformation method
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
EP0575546A4 (en) Prad1 cyclin and its cdna
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
NZ190524A (en) Recombinant dna method for producing specific protein or polypeptide cleaving of bacterial gene for extracellular or periplasmic carrier protein
NZ334721A (en) Purified human alpha-galactosidase A and therapeutic use
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
EP0182448A3 (en) Production of factor viii and related products
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
KR880700855A (ko) 진핵생물 단백질을 발현시키는 개선된 방법
KR890005264A (ko) 인터류킨-2를 생산하는 재조합 진핵 세포, 그의 제조 방법 및 그의 제조용 벡터 및 인터류킨-2의 제조방법
FR2559781B3 (fr) Nouveau vecteur plasmidique hybride de e. coli conferant le pouvoir de faire fermenter le saccharose et son procede de preparation
EP0222591A3 (en) Method and nucleic acid for the preparation of lecithin: cholesterol acyltransferase
AU7526881A (en) Method of plant tissue + cell culture
IL129139A0 (en) Vertebrate smoothened proteins
IL111983A0 (en) Methods for producing protein c
MX9704780A (es) Antigeno de fas humano secretado.
ATE107959T1 (de) Klonierung des isoamylaseenzym kodierenden gens und seine verwendung zur herstellung dieses enzyms.
HK1028789A1 (en) High level of expression of ingap.
EP0163243A3 (en) Improved human t or b cell lines and a process for producing immunologically active substances using the same
AU6560886A (en) DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells